DIN 02419157 — BOSULIF 500 MG
BOSULIF is a tablet of Bosutinib marketed by PFIZER CANADA ULC. The full Bosutinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02419157
- Brand name
- BOSULIF
- Active ingredient
- Bosutinib
- Strength
- 500 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- Protein-tyrosine kinase inhibitor (BCR-ABL inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Bosutinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02419149 | BOSULIF | 100 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02560038 | REDDY-BOSUTINIB | 100 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02560046 | REDDY-BOSUTINIB | 500 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |